{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:59:59Z","timestamp":1762869599288,"version":"3.44.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82374288"],"award-info":[{"award-number":["No. 82374288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese Medicine Science and Technology Project of Shandong Province in 2020","award":["No. 2020M108"],"award-info":[{"award-number":["No. 2020M108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16615-z","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T12:31:52Z","timestamp":1756038712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaoping","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keer","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"16615_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"16615_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","volume":"21","author":"DS Ettinger","year":"2023","unstructured":"Ettinger, D. S. et al. NCCN guidelines insights: Non-small cell lung cancer, version 2.2023. J. Natl. Comp. Cancer Netw. 21, 340\u2013350. https:\/\/doi.org\/10.6004\/jnccn.2023.0020 (2023).","journal-title":"J. Natl. Comp. Cancer Netw."},{"key":"16615_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.lungcan.2018.11.031","volume":"128","author":"JF Shi","year":"2019","unstructured":"Shi, J. F. et al. Clinical characteristics and medical service utilization of lung cancer in China, 2005\u20132014: Overall design and results from a multicenter retrospective epidemiologic survey. Lung Cancer 128, 91\u2013100. https:\/\/doi.org\/10.1016\/j.lungcan.2018.11.031 (2019).","journal-title":"Lung Cancer"},{"key":"16615_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam, S. S. et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N. Engl. J. Med. 382, 41\u201350. https:\/\/doi.org\/10.1056\/NEJMoa1913662 (2020).","journal-title":"N. Engl. J. Med."},{"key":"16615_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3892\/ijo.2018.4280","volume":"52","author":"ZJ Han","year":"2018","unstructured":"Han, Z. J., Feng, Y. H., Gu, B. H., Li, Y. M. & Chen, H. The post-translational modification, SUMOylation, and cancer (review). Int. J. Oncol. 52, 1081\u20131094. https:\/\/doi.org\/10.3892\/ijo.2018.4280 (2018).","journal-title":"Int. J. Oncol."},{"key":"16615_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3892\/mmr.2014.1882","volume":"9","author":"Y Qin","year":"2014","unstructured":"Qin, Y. et al. SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma. Mol. Med. Rep. 9, 877\u2013881. https:\/\/doi.org\/10.3892\/mmr.2014.1882 (2014).","journal-title":"Mol. Med. Rep."},{"key":"16615_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.biochem.73.011303.074118","volume":"73","author":"ES Johnson","year":"2004","unstructured":"Johnson, E. S. Protein modification by SUMO. Annu. Rev. Biochem. 73, 355\u2013382. https:\/\/doi.org\/10.1146\/annurev.biochem.73.011303.074118 (2004).","journal-title":"Annu. Rev. Biochem."},{"key":"16615_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/circresaha.110.220491","volume":"107","author":"J Wang","year":"2010","unstructured":"Wang, J. & Schwartz, R. J. Sumoylation and regulation of cardiac gene expression. Circ. Res. 107, 19\u201329. https:\/\/doi.org\/10.1161\/circresaha.110.220491 (2010).","journal-title":"Circ. Res."},{"key":"16615_CR9","doi-asserted-by":"publisher","first-page":"C284","DOI":"10.1152\/ajpcell.00091.2016","volume":"311","author":"F Liebelt","year":"2016","unstructured":"Liebelt, F. & Vertegaal, A. C. Ubiquitin-dependent and independent roles of SUMO in proteostasis. Am. J. Physiol. Cell Physiol. 311, C284-296. https:\/\/doi.org\/10.1152\/ajpcell.00091.2016 (2016).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"16615_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2011.10.036","volume":"316","author":"K Bettermann","year":"2012","unstructured":"Bettermann, K., Benesch, M., Weis, S. & Haybaeck, J. SUMOylation in carcinogenesis. Cancer Lett. 316, 113\u2013125. https:\/\/doi.org\/10.1016\/j.canlet.2011.10.036 (2012).","journal-title":"Cancer Lett."},{"key":"16615_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.tibs.2015.09.006","volume":"40","author":"K Eifler","year":"2015","unstructured":"Eifler, K. & Vertegaal, A. C. O. SUMOylation-mediated regulation of cell cycle progression and cancer. Trends Biochem. Sci. 40, 779\u2013793. https:\/\/doi.org\/10.1016\/j.tibs.2015.09.006 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"16615_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.1212728","volume":"335","author":"JD Kessler","year":"2012","unstructured":"Kessler, J. D. et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335, 348\u2013353. https:\/\/doi.org\/10.1126\/science.1212728 (2012).","journal-title":"Science"},{"key":"16615_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.stemcr.2016.11.001","volume":"7","author":"MV Bogachek","year":"2016","unstructured":"Bogachek, M. V. et al. Inhibiting the SUMO pathway represses the cancer stem cell population in breast and colorectal carcinomas. Stem Cell Rep. 7, 1140\u20131151. https:\/\/doi.org\/10.1016\/j.stemcr.2016.11.001 (2016).","journal-title":"Stem Cell Rep."},{"key":"16615_CR14","doi-asserted-by":"publisher","first-page":"12326","DOI":"10.1038\/ncomms12326","volume":"7","author":"L Du","year":"2016","unstructured":"Du, L. et al. Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal. Nat. Commun. 7, 12326. https:\/\/doi.org\/10.1038\/ncomms12326 (2016).","journal-title":"Nat. Commun."},{"key":"16615_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/s1470-2045(16)30033-x","volume":"17","author":"K Park","year":"2016","unstructured":"Park, K. et al. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): A phase 2B, open-label, randomised controlled trial. Lancet Oncol. 17, 577\u2013589. https:\/\/doi.org\/10.1016\/s1470-2045(16)30033-x (2016).","journal-title":"Lancet Oncol."},{"key":"16615_CR16","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/annonc\/mdx702","volume":"29","author":"WH Hsu","year":"2018","unstructured":"Hsu, W. H., Yang, J. C., Mok, T. S. & Loong, H. H. Overview of current systemic management of EGFR-mutant NSCLC. Ann. Oncol. 29, i3\u2013i9. https:\/\/doi.org\/10.1093\/annonc\/mdx702 (2018).","journal-title":"Ann. Oncol."},{"key":"16615_CR17","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/annonc\/mdx704","volume":"29","author":"J Remon","year":"2018","unstructured":"Remon, J., Steuer, C. E., Ramalingam, S. S. & Felip, E. Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Ann. Oncol. 29, i20\u2013i27. https:\/\/doi.org\/10.1093\/annonc\/mdx704 (2018).","journal-title":"Ann. Oncol."},{"key":"16615_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nm.3854","volume":"21","author":"KS Thress","year":"2015","unstructured":"Thress, K. S. et al. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. Nat. Med. 21, 560\u2013562. https:\/\/doi.org\/10.1038\/nm.3854 (2015).","journal-title":"Nat. Med."},{"key":"16615_CR19","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.xinn.2021.100103","volume":"2","author":"X Du","year":"2021","unstructured":"Du, X. et al. Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors. Innovation 2, 100103. https:\/\/doi.org\/10.1016\/j.xinn.2021.100103 (2021).","journal-title":"Innovation"},{"key":"16615_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.carbpol.2016.06.112","volume":"152","author":"M Alwarsamy","year":"2016","unstructured":"Alwarsamy, M., Gooneratne, R. & Ravichandran, R. Effect of fucoidan from Turbinaria conoides on human lung adenocarcinoma epithelial (A549) cells. Carbohydr. Polym. 152, 207\u2013213. https:\/\/doi.org\/10.1016\/j.carbpol.2016.06.112 (2016).","journal-title":"Carbohydr. Polym."},{"key":"16615_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"16615_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"16615_CR23","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141 (2021).","journal-title":"Innovation"},{"key":"16615_CR24","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson, E. K., Zhang, D., Reynolds, R. H., Garcia-Ruiz, S. & Ryten, M. ggtranscript: An R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics 38, 3844\u20133846. https:\/\/doi.org\/10.1093\/bioinformatics\/btac409 (2022).","journal-title":"Bioinformatics"},{"key":"16615_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scog.2017.10.001","volume":"11","author":"IS Ramsay","year":"2018","unstructured":"Ramsay, I. S. et al. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr. Res. Cogn. 11, 1\u20135. https:\/\/doi.org\/10.1016\/j.scog.2017.10.001 (2018).","journal-title":"Schizophr. Res. Cogn."},{"key":"16615_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341x.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty, P. J., Lumley, T. & Pepe, M. S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56, 337\u2013344. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00337.x (2000).","journal-title":"Biometrics"},{"key":"16615_CR27","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v079.c02","author":"MC Sachs","year":"2017","unstructured":"Sachs, M. C. plotROC: A tool for plotting ROC curves. J. Stat. Softw. https:\/\/doi.org\/10.18637\/jss.v079.c02 (2017).","journal-title":"J. Stat. Softw."},{"key":"16615_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinform."},{"key":"16615_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 18, 248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019 (2017).","journal-title":"Cell Rep."},{"key":"16615_CR30","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D. C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: Efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118 (2018).","journal-title":"Genome Res."},{"key":"16615_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/jir.S439315","volume":"17","author":"YJ Zhang","year":"2024","unstructured":"Zhang, Y. J., Huang, C., Zu, X. G., Liu, J. M. & Li, Y. J. Use of machine learning for the identification and validation of immunogenic cell death biomarkers and immunophenotypes in coronary artery disease. J. Inflamm. Res. 17, 223\u2013249. https:\/\/doi.org\/10.2147\/jir.S439315 (2024).","journal-title":"J. Inflamm. Res."},{"key":"16615_CR32","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim, N. et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat. Commun. 11, 2285. https:\/\/doi.org\/10.1038\/s41467-020-16164-1 (2020).","journal-title":"Nat. Commun."},{"key":"16615_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-023-04056-z","volume":"21","author":"Z Tan","year":"2023","unstructured":"Tan, Z. et al. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. J. Transl. Med. 21, 223. https:\/\/doi.org\/10.1186\/s12967-023-04056-z (2023).","journal-title":"J. Transl. Med."},{"key":"16615_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-022-02783-y","volume":"23","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Sun, D. & Wang, C. Evaluation of cell-cell interaction methods by integrating single-cell RNA sequencing data with spatial information. Genome Biol. 23, 218. https:\/\/doi.org\/10.1186\/s13059-022-02783-y (2022).","journal-title":"Genome Biol."},{"key":"16615_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.760954","volume":"12","author":"Y Rao","year":"2021","unstructured":"Rao, Y. et al. Single-cell transcriptome profiling identifies phagocytosis-related dual-feature cells in a model of acute otitis media in rats. Front. Immunol. 12, 760954. https:\/\/doi.org\/10.3389\/fimmu.2021.760954 (2021).","journal-title":"Front. Immunol."},{"key":"16615_CR36","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","volume":"22","author":"DC Altieri","year":"2003","unstructured":"Altieri, D. C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22, 8581\u20138589. https:\/\/doi.org\/10.1038\/sj.onc.1207113 (2003).","journal-title":"Oncogene"},{"key":"16615_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41598-020-79736-7","volume":"11","author":"L Xu","year":"2021","unstructured":"Xu, L., Yu, W., Xiao, H. & Lin, K. BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration. Sci. Rep. 11, 390. https:\/\/doi.org\/10.1038\/s41598-020-79736-7 (2021).","journal-title":"Sci. Rep."},{"key":"16615_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10549-016-3961-2","volume":"159","author":"AS Hamy","year":"2016","unstructured":"Hamy, A. S. et al. BIRC5 (survivin): A pejorative prognostic marker in stage II\/III breast cancer with no response to neoadjuvant chemotherapy. Breast Cancer Res. Treat. 159, 499\u2013511. https:\/\/doi.org\/10.1007\/s10549-016-3961-2 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"16615_CR39","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/jso.25253","volume":"118","author":"L Zhou","year":"2018","unstructured":"Zhou, L. et al. High nuclear survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma. J. Surg. Oncol. 118, 1115\u20131121. https:\/\/doi.org\/10.1002\/jso.25253 (2018).","journal-title":"J. Surg. Oncol."},{"key":"16615_CR40","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/mc.22238","volume":"54","author":"NJ Taylor","year":"2015","unstructured":"Taylor, N. J. et al. Genetic variation in cell cycle regulatory gene AURKA and association with intrinsic breast cancer subtype. Mol. Carcinog. 54, 1668\u20131677. https:\/\/doi.org\/10.1002\/mc.22238 (2015).","journal-title":"Mol. Carcinog."},{"key":"16615_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41591-018-0264-7","volume":"25","author":"KN Shah","year":"2019","unstructured":"Shah, K. N. et al. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat. Med. 25, 111\u2013118. https:\/\/doi.org\/10.1038\/s41591-018-0264-7 (2019).","journal-title":"Nat. Med."},{"key":"16615_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-024-06577-x","volume":"15","author":"B Deng","year":"2024","unstructured":"Deng, B. et al. AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis. Cell Death Dis. 15, 233. https:\/\/doi.org\/10.1038\/s41419-024-06577-x (2024).","journal-title":"Cell Death Dis."},{"key":"16615_CR43","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41467-022-29629-2","volume":"13","author":"S Cohen","year":"2022","unstructured":"Cohen, S. et al. A POLD3\/BLM dependent pathway handles DSBs in transcribed chromatin upon excessive RNA:DNA hybrid accumulation. Nat. Commun. 13, 2012. https:\/\/doi.org\/10.1038\/s41467-022-29629-2 (2022).","journal-title":"Nat. Commun."},{"key":"16615_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1083\/jcb.201307043","volume":"204","author":"J Chen","year":"2014","unstructured":"Chen, J., Smoyer, C. J., Slaughter, B. D., Unruh, J. R. & Jaspersen, S. L. The SUN protein Mps3 controls Ndc1 distribution and function on the nuclear membrane. J. Cell Biol. 204, 523\u2013539. https:\/\/doi.org\/10.1083\/jcb.201307043 (2014).","journal-title":"J. Cell Biol."},{"key":"16615_CR45","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s11010-022-04449-6","volume":"477","author":"X Li","year":"2022","unstructured":"Li, X. et al. Nuclear receptor subfamily 3 group c member 2 (NR3C2) is downregulated due to hypermethylation and plays a tumor-suppressive role in colon cancer. Mol. Cell. Biochem. 477, 2669\u20132679. https:\/\/doi.org\/10.1007\/s11010-022-04449-6 (2022).","journal-title":"Mol. Cell. Biochem."},{"key":"16615_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.33594\/000000351","volume":"55","author":"TS Walters","year":"2021","unstructured":"Walters, T. S. et al. SUMO-modification of human Nrf2 at K(110) and K(533) regulates its nucleocytoplasmic localization, stability and transcriptional activity. Cell. Physiol. Biochem. 55, 141\u2013159. https:\/\/doi.org\/10.33594\/000000351 (2021).","journal-title":"Cell. Physiol. Biochem."},{"key":"16615_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.122","volume":"3","author":"YY Sun","year":"2024","unstructured":"Sun, Y. Y. et al. Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer. Cancer Innov. 3, e122. https:\/\/doi.org\/10.1002\/cai2.122 (2024).","journal-title":"Cancer Innov."},{"key":"16615_CR48","doi-asserted-by":"publisher","first-page":"1058493","DOI":"10.3389\/fimmu.2022.1058493","volume":"13","author":"K Chen","year":"2022","unstructured":"Chen, K., Liu, S., Lu, C. & Gu, X. A prognostic and therapeutic hallmark developed by the integrated profile of basement membrane and immune infiltrative landscape in lung adenocarcinoma. Front. Immunol. 13, 1058493. https:\/\/doi.org\/10.3389\/fimmu.2022.1058493 (2022).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16615-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:09:06Z","timestamp":1756390146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16615-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16615"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16615-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31130"}}